UniCredit Knock-Out A2A/ DE000HC1RK28 /

24/05/2024 19:30:10	Chg.-0.020	Bid21:54:01	Ask21:54:01	Underlying	Strike price	Expiration date	Option type
0.910EUR	-2.15%	0.920 Bid Size: 6,000	0.930 Ask Size: 6,000	A2A	0.9739 EUR	31/12/2078	Call

GlobeNewswire 10/05 iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire 06/05 Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 19/03 Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financ...

Newsfile Corp 08/03 Noda Presents Report on Key Payment Trends: Diverse PaymentMethods, AI, and More

GlobeNewswire 06/03 iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

GlobeNewswire 08/01 iTeos Announces 2024 Strategic Priorities and Anticipated Milestones

GlobeNewswire 28/11/2023 Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

GlobeNewswire 07/11/2023 Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire 07/11/2023 iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates

GlobeNewswire 06/11/2023 Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy...

Newsfile Corp 04/10/2023 Noda and Tickets Travel Network Forge Partnership for Seamless Travel Payments

GlobeNewswire 21/09/2023 Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice Preside...

GlobeNewswire 20/09/2023 Innovative Payment Solutions Announces Funding of Second $500,000 Capital Contribution to IPSIPay Ex...

GlobeNewswire 05/09/2023 Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagon...

GlobeNewswire 30/08/2023 Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update

GlobeNewswire 10/03/2022 Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financ...

GlobeNewswire 03/03/2022 Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Finan...

GlobeNewswire 10/02/2022 Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2021

GlobeNewswire 02/02/2022 Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer

GlobeNewswire 14/01/2022 Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial o...

GlobeNewswire 03/01/2022 iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 09/12/2021 iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology...

GlobeNewswire 12/11/2021 Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial ...

GlobeNewswire 10/11/2021 Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GlobeNewswire 03/11/2021 iTeos to Report Third Quarter 2021 Financial Results on November 10, 2021